https://www.selleckchem.com/products/icg-001.html
Takotsubo syndrome (TTS) is estimated to account for 1-3% of all patients presenting with suspected ST-segment elevation myocardial infarction. A sudden surge in sympathetic nervous system is considered the cause of TTS. Nonetheless, no specific recommendations have been provided regarding β-blocking therapy. Apart from specific contra-indications (severe LV dysfunction, hypotension, bradycardia and corrected QT interval 500 ms), treatment with a β-blocker seems reasonable until full recovery of LV ejection fraction, though evidence
Like
Comment
Share
